Villareal Dennis T, Koster Joseph C, Robertson Heather, Akrouh Alejandro, Miyake Kazuaki, Bell Graeme I, Patterson Bruce W, Nichols Colin G, Polonsky Kenneth S
Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.
Diabetes. 2009 Aug;58(8):1869-78. doi: 10.2337/db09-0025. Epub 2009 Jun 2.
The E23K variant in the Kir6.2 subunit of the ATP-sensitive K(+) channel (K(ATP) channel) is associated with increased risk of type 2 diabetes. The present study was undertaken to increase our understanding of the mechanisms responsible. To avoid confounding effects of hyperglycemia, insulin secretion and action were studied in subjects with the variant who had normal glucose tolerance.
Nine subjects with the E23K genotype K/K and nine matched subjects with the E/E genotype underwent 5-h oral glucose tolerance tests (OGTTs), graded glucose infusion, and hyperinsulinemic-euglycemic clamp with stable-isotope-labeled tracer infusions to assess insulin secretion, action, and clearance. A total of 461 volunteers consecutively genotyped for the E23K variant also underwent OGTTs. Functional studies of the wild-type and E23K variant potassium channels were conducted.
Insulin secretory responses to oral and intravenous glucose were reduced by approximately 40% in glucose-tolerant subjects homozygous for E23K. Normal glucose tolerance with reduced insulin secretion suggests a change in insulin sensitivity. The hyperinsulinemic-euglycemic clamp revealed that hepatic insulin sensitivity is approximately 40% greater in subjects with the E23K variant, and these subjects demonstrate increased insulin sensitivity after oral glucose. The reconstituted E23K channels confirm reduced sensitivity to inhibitory ATP and increase in open probability, a direct molecular explanation for reduced insulin secretion.
The E23K variant leads to overactivity of the K(ATP) channel, resulting in reduced insulin secretion. Initially, insulin sensitivity is enhanced, thereby maintaining normal glucose tolerance. Presumably, over time, as insulin secretion falls further or insulin resistance develops, glucose levels rise resulting in type 2 diabetes.
ATP敏感性钾通道(KATP通道)Kir6.2亚基中的E23K变异与2型糖尿病风险增加相关。本研究旨在增进我们对其潜在机制的理解。为避免高血糖的混杂影响,我们在糖耐量正常的该变异受试者中研究了胰岛素分泌及作用。
9名E23K基因型为K/K的受试者和9名匹配的E/E基因型受试者接受了5小时口服葡萄糖耐量试验(OGTT)、分级葡萄糖输注以及采用稳定同位素标记示踪剂输注的高胰岛素正常血糖钳夹试验,以评估胰岛素分泌、作用及清除情况。另外,共有461名连续进行E23K变异基因分型的志愿者也接受了OGTT。同时对野生型和E23K变异钾通道进行了功能研究。
E23K纯合的糖耐量正常受试者对口服和静脉注射葡萄糖的胰岛素分泌反应降低了约40%。糖耐量正常但胰岛素分泌减少提示胰岛素敏感性发生了变化。高胰岛素正常血糖钳夹试验显示,E23K变异受试者的肝脏胰岛素敏感性大约高40%,并且这些受试者在口服葡萄糖后表现出胰岛素敏感性增加。重组的E23K通道证实对抑制性ATP的敏感性降低且开放概率增加,这是胰岛素分泌减少的直接分子学解释。
E23K变异导致KATP通道活性过高,从而导致胰岛素分泌减少。最初,胰岛素敏感性增强,从而维持正常糖耐量。据推测,随着时间推移,由于胰岛素分泌进一步下降或胰岛素抵抗出现,血糖水平升高,进而导致2型糖尿病。